Super Formulations Profile
Key Indicators
- Authorised Capital ₹ 1.50 Cr
as on 04-12-2024
- Paid Up Capital ₹ 1.50 Cr
as on 04-12-2024
- Company Age 20 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 43.43 Cr
as on 04-12-2024
- Revenue 85.01%
(FY 2022)
- Profit 93.01%
(FY 2022)
- Ebitda 56.09%
(FY 2022)
- Net Worth 28.65%
(FY 2022)
- Total Assets 68.05%
(FY 2022)
About Super Formulations
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 Cr and a paid-up capital of Rs 1.50 Cr.
The company currently has active open charges totaling ₹43.43 Cr.
Jain Lavish and Meghant Jain serve as directors at the Company.
- CIN/LLPIN
U24232MP2004PTC016782
- Company No.
016782
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Jul 2004
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Gwalior
Industry
Company Details
- Location
Ujjain, Madhya Pradesh, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Super Formulations Private Limited offer?
Super Formulations Private Limited offers a wide range of products and services, including Pharmaceutical Tablets, Tablets, Nutraceuticals & Dietary Supplements, Dietary Supplements.
Who are the key members and board of directors at Super Formulations?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jain Lavish  | Managing Director | 26-Jul-2004 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Meghant Jain | Director | 24-Dec-2021 | Current |
Financial Performance of Super Formulations.
Super Formulations Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 85.01% increase. The company also saw a substantial improvement in profitability, with a 93.01% increase in profit. The company's net worth Soared by an impressive increase of 28.65%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Super Formulations?
In 2022, Super Formulations had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 27 Jun 2022 | ₹1.50 Cr | Open |
Hdfc Bank Limited Creation Date: 30 Nov 2021 | ₹22.74 Cr | Open |
Sidbi Creation Date: 14 Sep 2021 | ₹2.00 Cr | Open |
How Many Employees Work at Super Formulations?
Super Formulations has a workforce of 32 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Super Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Super Formulations's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
